CAS 1254473-64-7

Ponatinib

CAS: 1254473-64-7

Formel: C₂₁H₁₉Cl₂N₅O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 444.3139

Ref: IN-DA000NOR

(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-Yl)Ethoxy)-1H-Indazol-3-Yl)Vinyl)-1H-Pyrazol-1-Yl)Ethan-1-Ol

CAS: 1254473-64-7

(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-Yl)Ethoxy)-1H-Indazol-3-Yl)Vinyl)-1H-Pyrazol-1-Yl)Ethan-1-Ol

Reinheit: 98%

Molekulargewicht: 444.31g/mol

Ref: 54-OR1024305

LY2874455

CAS: 1254473-64-7

LY2874455

Reinheit: ≥95%

Molekulargewicht: 444.31g/mol

Ref: 54-BUP12288

LY2874455

CAS: 1254473-64-7

LY2874455 has been used in trials studying the treatment of Advanced Cancer.

Formel: C₂₁H₁₉Cl₂N₅O₂

Reinheit: 97.22% - 99.46%

Farbe und Form: Solid

Molekulargewicht: 444.31

Ref: TM-T2361

LY 2874455

CAS: 1254473-64-7

Inhibitor of FGFR kinase

Formel: C₂₁H₁₉Cl₂N₅O₂

Reinheit: (%) Min. 98%

Molekulargewicht: 443.09158

Ref: 3D-FL137697

LY 2874455

Kontrolliertes Produkt

CAS: 1254473-64-7

Applications LY 2874455 is a pan-FGFR inhibitor which remain the focus of research for use in lung and bladder cancers.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Gozgit, J. et al.: Mol. Cancer Ther., 11, 690 (2012); Zhao, G. et al.: Mol. Cancer Ther., 10, 2200 (2011);

Formel: C₂₁H₁₉Cl₂N₅O₂

Farbe und Form: Neat

Molekulargewicht: 444.31

Ref: TR-L486580